ARTICLE SUMMARY:
Primary care clinicians are most likely to encounter patients harboring early, subclinical cardiac changes. Historically, however, they have lacked objective tools to identify such patients. Now Ventric Health offers an FDA-cleared screening tool called Vivio, to catch early signs of heart failure, to interrupt the course of this degenerative condition. A companion article to "Innovating Heart Failure: Start-Ups Harness Natural Pathways."
Heart failure is a complex clinical syndrome that evolves across stages and presents with diverse symptoms arising from multiple underlying causes. Yet one principle is universal: the earlier heart failure is identified and treated, the better the patient’s quality of life and long-term outcomes. Early detection is the mission of Ventric Health, whose FDA-cleared, office-based system, Vivio, is designed to help primary care physicians identify and triage patients with early-stage heart failure—before structural damage and overt symptoms fully manifest.
Primary care clinicians are most likely to encounter patients harboring early, subclinical cardiac changes. Historically, however, they have lacked objective tools to identify such patients. Instead, clinicians rely on risk factors, comorbidities, and symptom reports—an approach complicated by overlapping complaints such as fatigue, dyspnea, or chest discomfort, if symptoms are reported at all.
